Differences in perspective on prognosis and treatment of children with trisomy 18

Edward H Hurley1, Sankaran Krishnan, Lance A Parton

  • 1Department of Pediatrics, Hasbro Children's Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island.

Insights

Physician perspectives on trisomy 18 care differ significantly. Pediatric pulmonologists are more optimistic and recommend interventions, while neonatologists favor comfort care, highlighting varied approaches to this genetic disorder.

Area of Science:

  • Genetics and Genetic Disorders
  • Pediatric Medicine
  • Medical Ethics

Background:

  • Parental stress and confusion arise from differing physician viewpoints on caring for children with trisomy 18.
  • Understanding these physician perspectives is crucial for consistent and supportive family care.
  • Trisomy 18 (Edwards syndrome) presents complex management challenges in pediatric care.

Purpose of the Study:

  • To investigate and compare the opinions of neonatologists and pediatric pulmonologists regarding long-term prognosis and interventions for trisomy 18.
  • To identify factors influencing physician recommendations for medical and surgical interventions in trisomy 18 cases.

Main Methods:

  • Survey distributed to neonatologists and pediatric pulmonologists in New York State.
  • Respondents reported experience with trisomy 18, prognosis opinions, influencing factors, and intervention likelihood for clinical vignettes.
  • Response rate: 20% for neonatologists (66/327) and 32% for pediatric pulmonologists (21/66).

Main Results:

  • Pediatric pulmonologists were significantly less likely to have cared for trisomy 18 patients compared to neonatologists (29% vs 2%).
  • Pediatric pulmonologists were more inclined to recommend aggressive interventions (e.g., mechanical ventilation, surgery, full resuscitation) than neonatologists.
  • Neonatologists were more likely to recommend comfort/palliative care and believed a higher percentage of patients would die before age one.

Conclusions:

  • Significant divergence exists between neonatologists and pediatric pulmonologists in their approach to trisomy 18 management.
  • Pediatric pulmonologists demonstrate greater optimism regarding prognosis and are more intervention-oriented.
  • Differences in clinical experience and perception of survivability likely contribute to these contrasting physician perspectives.

Related Concept Videos

Karyotyping01:17

Karyotyping

Overview
49.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
39.3K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.0K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
653
Meiosis I01:49

Meiosis I

Meiosis is a carefully orchestrated set of cell divisions, the goal of which—in humans—is to produce haploid sperm or eggs, each containing half the number of chromosomes present in somatic cells elsewhere in the body. Meiosis I is the first such division, and involves several key steps, among them: condensation of replicated chromosomes in diploid cells; the pairing of homologous chromosomes and their exchange of information; and finally, the separation of homologous chromosomes by...
176.5K